萩原真紀

ハギハラマキ | Hagihara Maki

所属機関・部署：
職名：講師
ホームページURL (2件)： http://www.ycuhri.com/ , http://www-user.yokohama-cu.ac.jp/~naika1/index.html

研究分野 (1件)：血液、腫瘍内科学

研究キーワード (1件)：造血幹細胞移植

MISC (31件)：

Yoshimi Ishii, Maki Hagihara, Ai Kato, Taiki Ando, Megumi Itabashi, Satoshi Koyama, Wataru Yamamoto, Kenji Motohashi, Kenji Matsumoto, Shin Fujisawa. Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients. LEUKEMIA & LYMPHOMA. 2016. 57. 2. 496-497
Naoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, Kazuho Miyashita, Hiroyuki Takahashi, Ayumi Numata, Satomi Ito, Kenji Motohashi, Takayoshi Tachibana, Hirotaka Takasaki, et al. R-CHOP therapy alone for limited-stage follicular lymphoma. LEUKEMIA RESEARCH. 2015. 39. 6. 582-585
Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy. [Rinshō ketsueki] The Japanese journal of clinical hematology. 2015. 56. 392-399
Naoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama, Kumiko Kishimoto, Daisuke Ishibashi, Satoshi Koyama, Yoshimi Ishii, Hiroyuki Takahashi, Ayumi Numata, Reina Watanabe, et al. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diff use large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone. LEUKEMIA & LYMPHOMA. 2015. 56. 3. 725-729
Yoshimi Ishii, Naoto Tomita, Ukihide Tateishi, Yasufumi Ishiyama, Eri Yamamoto, Yukako Hattori, Maki Hagihara, Etsuko Yamazaki, Yoshiaki Ishigatsubo. The rate of reduction in the maximum standardized uptake value from the initial to the post-R-CHOP therapy in positron emission tomography scan predicts disease progression in diffuse large B cell lymphoma patients. MEDICAL ONCOLOGY. 2014. 31. 3

学位 (1件)：

博士(医学) (横浜市立大学)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

萩原 真紀

萩原真紀